Pacira BioSciences Inc.

PCRX | NASDAQ

Price Alert Chart Builder DCF Calculator

$24.75

+$0.64 (+2.65%)

Sep 22, 2026, 2:37 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $948.37M

Enterprise Value $1.11B

Beta 0.27

Average Volume 565.85K

Shares Outstanding (Diluted) 40.3M

Shares Change YoY -11.35%

Institutional Ownership N/A

Exchange NASDAQ

ISIN US6951271005

Price Performance

Price Change 1M -2.8%

Price Change 3M 2.5%

Price Change 6M 2.6%

Price Change YTD -1.4%

Price Change 1Y -8.9%

Price Change 3Y -27.3%

Price Change 5Y -58.3%

1M CAGR (ann.) -3.6%

1Y CAGR (ann.) -9.5%

5Y CAGR (ann.) -15.4%

All-Time CAGR 8.2%

Valuation

PE Ratio 68.89

Forward PE 6.13

PEG Ratio 1.06

Forward PEG 3.61

PS Ratio 1.27

Forward PS 1.20

PB Ratio 1.41

P/FCF Ratio 4.68

P/Adj. FCF Ratio 7.13

P/OCF Ratio 5.07

EV/Sales 1.49

EV/EBIT 37.49

EV/EBITDA 9.67

EV/FCF 5.48

Earnings Yield 1.4%

FCF Yield 21.4%

Adj. FCF Yield 14.0%

Financial Health

Net Debt $112.09M

Total Debt $412.12M

Cash & Short-Term Investments $251.03M

Total Assets $1.24B

Current Ratio 5.04

Quick Ratio 3.94

Debt / Equity Ratio 0.61

Debt / EBITDA 3.59

Debt / FCF 2.04

OCF / Debt 0.52

Interest Coverage 1.33

Altman Z-Score 1.93

Piotroski F-Score 8

Margins & Profitability

Gross Profit Margin 79.2%

Operating Profit Margin 2.5%

EBITDA Margin 15.4%

Net Profit Margin 2.0%

FCF Margin 27.1%

Adj. FCF Margin 17.8%

SBC / Revenue 7.5%

SBC Impact (per share) -34.3%

Returns

Return on Assets 1.2%

Return on Equity 2.1%

Return on Invested Capital 1.4%

Return on Capital Employed 1.6%

Return on Tangible Assets 1.6%

Historical Growth (CAGR)

Revenue CAGR 3Y 3.7%

Revenue CAGR 5Y 8.2%

Revenue CAGR 10Y 10.8%

EPS CAGR 3Y -123.7%

EPS CAGR 5Y -38.3%

EPS CAGR 10Y 16.7%

FCF CAGR 3Y 16.9%

FCF CAGR 5Y 19.6%

FCF CAGR 10Y 23.3%

Analyst Forecasts

Analyst Rating Hold

Analyst Count 36

EPS Growth Next 3Y 132.2%

Revenue Growth Next 3Y 5.1%

Earnings Date Nov 4, 2026

EPS Estimate (next Q) $0.76

EPS Growth Est (next Q) 8.6%

Revenue Est (next Q) $182.21M

Revenue Growth Est (next Q) 1.5%

Fair Value Estimates

Graham Number $11.58

Graham Upside -52.0%

Lynch Fair Value $1.75

Lynch Upside -92.7%

Price Target $28.75

Price Target Upside 19.2%

Cash Flow

Operating Cash Flow $213.34M

Free Cash Flow $202.47M

Adj. Free Cash Flow $132.96M

FCF Per Share $4.55

OCF Per Share $4.76

OCF/S Ratio 25.2%

Income Statement

Revenue $746.16M

Gross Profit $591.01M

Operating Income $18.45M

EBITDA $114.76M

Net Income $14.64M

EPS (Diluted) $0.35

Revenue / Employee $902.25K

Profit / Employee $17.7K

Employees 827